As of 2024-12-14, the Relative Valuation of Applied Therapeutics Inc (APLT) is (33.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.14 USD, the upside of Applied Therapeutics Inc based on Relative Valuation is -3070.1%.
The range of the Relative Valuation is (39.59) - (40.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 17.5x | 17.3x |
| Forward P/E multiples | 5.1x - 18.8x | 12.0x |
| Fair Price | (39.59) - (40.52) | (33.86) |
| Upside | -3572.8% - -3654.0% | -3070.1% |
| Date | P/E |
| 2024-12-04 | -0.60 |
| 2024-12-03 | -0.73 |
| 2024-12-02 | -0.76 |
| 2024-11-29 | -0.88 |
| 2024-11-27 | -3.70 |
| 2024-11-26 | -4.41 |
| 2024-11-25 | -4.14 |
| 2024-11-22 | -4.16 |
| 2024-11-21 | -4.00 |
| 2024-11-20 | -4.07 |
| 2024-11-19 | -3.86 |
| 2024-11-18 | -3.74 |
| 2024-11-15 | -3.75 |
| 2024-11-14 | -3.89 |
| 2024-11-13 | -3.85 |
| 2024-11-12 | -4.28 |
| 2024-11-11 | -4.42 |
| 2024-11-08 | -4.36 |
| 2024-11-07 | -4.21 |
| 2024-11-06 | -4.17 |
| 2024-11-05 | -4.16 |
| 2024-11-04 | -4.00 |
| 2024-11-01 | -3.93 |
| 2024-10-31 | -3.82 |
| 2024-10-30 | -3.90 |
| 2024-10-29 | -3.78 |
| 2024-10-28 | -3.73 |
| 2024-10-25 | -3.64 |
| 2024-10-24 | -3.85 |
| 2024-10-23 | -3.87 |
| 2024-10-22 | -3.77 |
| 2024-10-21 | -3.88 |
| 2024-10-18 | -3.87 |
| 2024-10-17 | -3.73 |
| 2024-10-16 | -3.80 |
| 2024-10-15 | -3.95 |
| 2024-10-14 | -3.84 |
| 2024-10-11 | -3.70 |
| 2024-10-10 | -3.54 |
| 2024-10-09 | -3.55 |
| 2024-10-08 | -3.54 |
| 2024-10-07 | -3.33 |
| 2024-10-04 | -3.33 |
| 2024-10-03 | -3.40 |
| 2024-10-02 | -3.62 |
| 2024-10-01 | -3.62 |
| 2024-09-30 | -3.67 |
| 2024-09-27 | -3.57 |
| 2024-09-26 | -3.63 |
| 2024-09-25 | -3.62 |